Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: George Burdell who wrote (32827)	1/19/2007 9:55:03 AM
From: micdundee2	Read Replies (1) \| Respond to of 48461

not hosed for me I have no idea if this is news its yhooooligan chat ---------------- View all Topics \| View all Messages < Newer Topic \| Older Topic > News links (Not rated) 4 minutes ago finance.google.com. In November 2006, Dr. Hruby of SIGA was one of the invited participants during the 8th meeting of the WHO Advisory Committee on Variola Virus Research. The report of the meeting has just been made public in the publications section of the WHO website at who.int. Particularly relevant to SIGA is Section 7 on Candidate Antiviral Drugs. The report gives an up-to-date sense of the entire scope of smallpox issues from a world perspective. The WHO has said that ST-246 is "8000 times" better than the leading candidate by Gilead Sciences, Cidofovir. Also, these were the ONLY two antiviral drug candidates mentioned. -------------- heres the screwed up links corrected who.int finance.google.com